( 06821.hk) | 46.77 | 2.70 | 0.96% (0.94%) | 上市时间2021-12-10股价153.700港币涨跌幅-1.54%成交金额4,427.79万港币换手率0.08%总市值554.34亿港币H股市值42.78亿港币总股本3.61亿H股本2,783.45万每手股数100 港股通持仓占H股比例49.58% (22.49亿港币2026-10-08) 累计做空占H股比例6.26% (2.91亿港币2026-10-02) 上市至今年化投资收益率-9.09% | |||
| 所属三级行业医药及生物科技合约服务 (恒生) | 市盈率 | 40.74 | 市净率 | 4.24 | 股息率 | 0.67% | 恒生:医疗保健业药品及生物科技医药及生物科技合约服务 |
| 所属指数指数纳入纳出 | |||||||
| 同股同权 | 查看历史折扣 | ||||||
| 备注 (5): | 双击编辑备注 |
凯莱英(06821) - 历史董事名单
| # | 姓名 | 职衔 | 职位 | 委任日期 | 辞任日期 |
|---|---|---|---|---|---|
| 1 | 孫雪嬌 | Independent Non Executive Director - A/F | 2023-10-18 | -- | |
| 2 | 李家聰 | Independent Non Executive Director | 2021-06-16 | -- | |
| 3 | 張婷 | Non Executive Director | 2021-02-09 | -- | |
| 4 | 王青松 | Independent Non Executive Director | 2019-04-18 | -- | |
| 5 | 張達 | Executive Director | 2018-08-07 | -- | |
| 6 | 張昆 | Independent Non Executive Director - A/F | 2017-01-16 | 2023-10-18 | |
| 7 | HONG Hao | Executive Director | Chairman, CEO | 2011-07-18 | -- |
| 8 | 洪亮 | Executive Director | 2011-07-18 | -- | |
| 9 | SONG Ye | Non Executive Director | 2011-07-18 | -- | |
| 10 | 楊蕊 | Executive Director | 2011-07-18 | -- |